510(k) K033106
K033106 is an FDA 510(k) premarket notification submitted by Trinity Biotech USA for the device "CAPTIA HSV 2 IGG TYPE SPECIFIC ELISA KIT". The FDA issued a decision of Substantially Equivalent on July 13, 2004. The device falls under product code MYF (Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2), a Class II device regulated under 21 CFR 866.3305. Trinity Biotech USA has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 13, 2004
- Date Received
- September 30, 2003
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2
- Device Class
- Class II
- Regulation Number
- 866.3305
- Review Panel
- MI
- Submission Type